SUBSCRIBE
SUBSCRIBE

Cartesian Therapeutics

NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Selecta’s IPO Expected Next Week; Sixth Biotech in Massachusetts to Go Public This Year
June 20, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Sanofi Adds Celiac Disease to the Menu With $300 Million Selecta Bet
May 13, 2015
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grant - June 12, 2026
June 14, 2026
 · 
1 min read
Press Releases
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
June 9, 2026
 · 
10 min read
Press Releases
Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027
May 26, 2026
 · 
11 min read
Press Releases
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 12, 2026
 · 
1 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grants - May 4, 2026
May 4, 2026
 · 
1 min read
Press Releases
Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
April 30, 2026
 · 
11 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grants - April 2, 2026
April 2, 2026
 · 
1 min read
Press Releases
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
March 9, 2026
 · 
14 min read
Press Releases
Cartesian Therapeutics to Participate in Upcoming Investor Conferences - February 23, 2026
February 23, 2026
 · 
1 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grants - February 3, 2026
February 3, 2026
 · 
1 min read
Load More